Breast Cancer Resiliency Through Exercise Program (B-REP)
ConditionBreast Cancer Female
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Michigan Rogel Cancer Center
About this trial
The study will use a cross-sectional study design with a follow-up 2-arm randomized controlled trial with that has assessments at baseline, post-intervention (i.e., Week 12), and 3-months post-intervention (i.e., Week 24). The 2 arms are the 12-week intervention and waitlist control among 30 Black breast cancer survivors
Eligibility criteria
Qualifiers
self-identify as Black or African American or Afro-Latina/e;
are ≥18 years old;
have a confirmed diagnosis of breast cancer, Stage I to IIIA;
have completed primary active treatment (i.e., surgery, chemotherapy, and radiation) within 5 years prior to study start where concomitant hormonal therapy is acceptable;
Disqualifiers
metastatic disease;
medical reason that precludes them from increasing current exercise levels;
planned elective surgery during study period;
pregnant or plans to become pregnant during the study period;
Trial design
Treatments tested in this trial
- Individualized exercise program
- Control Arm
Treatment groups
75 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov